Global Generics Market Report 2022: Identifying the Size, Growth, and Leading Players in the Sector – ResearchAndMarkets.com

Global Generics Market Report 2022: Identifying the Size, Growth, and Leading Players in the Sector – ResearchAndMarkets.com




Global Generics Market Report 2022: Identifying the Size, Growth, and Leading Players in the Sector – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Generics Market Summary, Competitive Analysis and Forecast, 2017-2026” report has been added to ResearchAndMarkets.com’s offering.

Global Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2017-21, and forecast to 2026). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

  • For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the ‘generic-eligible’ market, are not included.
  • The market value is evaluated at ex-factory prices.
  • Market volume is quantified here as the percentage of the total ethical pharmaceutical market volume in a country or region which is accounted for by generic drugs. It is therefore a generics penetration rate measure, not an absolute measure of market volume.
  • Regional volumes are calculated as weighted averages of countries which make up the region in question where volume data exists.
  • All market data and forecasts are represented in nominal terms (i.e., without adjustment for inflation) and all currency conversions used in the creation of this report have been calculated using constant 2021 annual average exchange rates.
  • The global generics market had total revenues of $321.4 billion in 2021, representing a compound annual growth rate (CAGR) of 4.7% between 2016 and 2021.
  • Market consumption volume increased with a CAGR of 1.9% between 2016 and 2021, to reach a total of 47.0 % in 2021.
  • Over the past five years, the global generics market recorded growth of 5.2%. Growth has primarily been driven by demographic trends.

Scope

  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the global generics market
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the global generics market
  • Leading company profiles reveal details of key generics market players’ global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the global generics market with five year forecasts by both value and volume

Key Topics Covered:

1 EXECUTIVE SUMMARY

2 Introduction

3 Global Generics

4 Macroeconomic Indicators

5 Generics in Asia-Pacific

6 Generics in Europe

7 Macroeconomic Indicators

8 Generics in France

9 Macroeconomic Indicators

10 Generics in Germany

11 Macroeconomic Indicators

12 Generics in Italy

13 Macroeconomic Indicators

14 Generics in Japan

15 Macroeconomic Indicators

16 Generics in Australia

17 Macroeconomic Indicators

18 Generics in Canada

19 Macroeconomic Indicators

20 Generics in China

21 Macroeconomic Indicators

22 Generics in The Netherlands

23 Macroeconomic Indicators

24 Generics in Spain

25 Macroeconomic Indicators

26 Generics in The United Kingdom

27 Macroeconomic Indicators

28 Generics in The United States

29 Macroeconomic Indicators

30 Company Profiles

31 Appendix

Companies Mentioned

  • Sun Pharmaceutical Industries Ltd
  • Les Laboratoires Servier
  • STADA Arzneimittel AG
  • Sanofi SA
  • Daiichi Sankyo Co Ltd
  • Sawai Pharmaceutical Co Ltd
  • Viatris Inc.
  • Aspen Pharmacare Holdings Ltd
  • Lupin Ltd
  • Apotex, Inc.
  • Grand Pharmaceutical Group Limited
  • Esteve Group
  • Teva Pharmaceutical Industries Limited
  • Pfizer Inc.

For more information about this report visit https://www.researchandmarkets.com/r/lo0355

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900